IDH1 and central nervous system cancer: Common genomic alterations in gliomas include mutations in IDH1, TP53, ATRX, and TERT promoter, amplification and rearrangements of EGFR, MET, and PDGFRA, as well as deletions of chromosome 1p/19q and CDKN2A[181], [182].